📰 Newspapers

250,000 Kenyans screened for diabetes, hypertension in Boehringer programme

250,000 Kenyans screened for diabetes, hypertension in Boehringer programme

Boehringer Ingelheim says it has screened more than 250,000 Kenyans and placed over 20,000 on treatment for diabetes and hypertension since 2022 through its Access to Healthcare programme targeting underserved communities.

NAIROBI,Kenya Nov 21 – German pharmaceutical company Boehringer Ingelheim says it has screened more than 250,000 Kenyans for diabetes and hypertension and enrolled over 20,000 patients on treatment since 2022, as it steps up efforts to tackle late diagnosis of non-communicable diseases.

The company, through its Access to Healthcare programme, has been taking screening services closer to communities, particularly in rural and underserved areas where access to medical facilities remains a challenge.

George Kuria, Boehringer Ingelheim’s Sustainable Development for Generations and Access to Health Manager for Sub-Saharan Africa, said the initiative was designed to identify patients early and link those diagnosed with the conditions to treatment and continued medical care.

“So far, we have been able to screen more than 250,000 patients since we started, and we have been able to put on treatment more than 20,000 patients in this programme,” Kuria said in an interview with Capital FM.

Implemented in partnership with healthcare providers, including Zuri Health, the programme uses community outreach clinics and screening camps to reach people who might otherwise go without routine medical checks.

Kuria attributed the high number of undiagnosed cases to poor health-seeking habits, the cost of treatment, limited access to medical facilities and inadequate public awareness about non-communicable diseases (NCDs).

In brief

NAIROBI,Kenya Nov 21 – German pharmaceutical company Boehringer Ingelheim says it has screened more than 250,000 Kenyans for diabetes and hypertension and enrolled over 20,000 patients on treatment since 2022, as it steps up efforts to tackle late diagnosis of non-communicable diseases. The company, through its Access to Healthcare programme, has been taking screening services closer to communities, particularly in rural and underserved areas where access to medical facilities remains a challenge.

This is the opening of the story, shared with credit to Capital FM Kenya. The rest of the report — with every detail — continues on the publisher’s website.

Continue reading at Capital FM Kenya ↗

Cookie settings

Choose which cookies we may use. You can change this at any time from Cookie settings in the footer. Details of each cookie are in the Cookie Policy.

Strictly necessary

Needed for sign-in, security, payments and remembering these choices. Always on.

Preferences

Remember settings such as dark mode.

Analytics & performance

Help us count visits, understand which pages, devices and countries our readers use, and measure how well the site performs – anonymous and aggregated.

Advertising & marketing

Lets advertising partners show and personalise adverts, measure impressions, clicks and visits, prevent ad fraud and pay us – this is how the free site is funded.

🔔 News notifications

Get headlines from NewsHub on this device — even when the site is closed.

You can switch this off at any time. Works on Android, Windows, Mac and Linux browsers; on iPhone/iPad add the site to your Home Screen first.